Obesity-induced type 2 diabetes may be associated with the dysregulation of GPR21 through an increase in receptor expression, an increase in an endogenous agonist or a reduction in an inverse agonist, leading to the stimulation of the MAPKs, which contribute to the inhibitory influences of GPR21. The gene discussed is GPR21; the disease is obesity disorder.